187 related articles for article (PubMed ID: 10199931)
21. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.
Glass EC; Essner R; Morton DL
J Nucl Med; 1998 Jul; 39(7):1185-90. PubMed ID: 9669391
[TBL] [Abstract][Full Text] [Related]
22. In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification.
Edreira MM; Colombo LL; Perez JH; Sajaroff EO; de Castiglia SG
Nucl Med Commun; 2001 May; 22(5):499-504. PubMed ID: 11388570
[TBL] [Abstract][Full Text] [Related]
23. Lymphoscintigraphy using larger colloid particles may enhance visualization of the sentinel node in breast cancer: a case report.
Liu TJ; Wang SJ; Tsai SC
Clin Nucl Med; 2000 Mar; 25(3):191-2. PubMed ID: 10698415
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.
Haigh PI; Hansen NM; Giuliano AE; Edwards GK; Ye W; Glass EC
J Nucl Med; 2000 Oct; 41(10):1682-8. PubMed ID: 11037998
[TBL] [Abstract][Full Text] [Related]
25. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping.
Wallace AM; Hoh CK; Ellner SJ; Darrah DD; Schulteis G; Vera DR
Ann Surg Oncol; 2007 Feb; 14(2):913-21. PubMed ID: 17146742
[TBL] [Abstract][Full Text] [Related]
26. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
[TBL] [Abstract][Full Text] [Related]
27. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
[TBL] [Abstract][Full Text] [Related]
28. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
[TBL] [Abstract][Full Text] [Related]
29. Penile lymphoscintigraphy for sentinel node identification.
Valdés Olmos RA; Tanis PJ; Hoefnagel CA; Jansen L; Nieweg OE; Meinhardt W; Horenblas S
Eur J Nucl Med; 2001 May; 28(5):581-5. PubMed ID: 11383862
[TBL] [Abstract][Full Text] [Related]
30. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
[TBL] [Abstract][Full Text] [Related]
31. Standardized probe-directed sentinel node dissection in melanoma.
Essner R; Bostick PJ; Glass EC; Foshag LJ; Haigh PI; Wang HJ; Morton DL
Surgery; 2000 Jan; 127(1):26-31. PubMed ID: 10660755
[TBL] [Abstract][Full Text] [Related]
32. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European survey.
Bongers V; Borel Rinkes IH; Barneveld PC; Canninga-van Dijk MR; van Rijk PP; van Vloten WA
Eur J Nucl Med; 1999 Feb; 26(2):84-90. PubMed ID: 9933341
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping.
Bartolomei M; Testori A; Chinol M; Gennari R; De Cicco C; Leonardi L; Zoboli S; Paganelli G
Eur J Nucl Med; 1998 Nov; 25(11):1489-94. PubMed ID: 9799344
[TBL] [Abstract][Full Text] [Related]
34. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.
Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886
[TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy in melanoma using technetium-99m rhenium colloid: the London experience.
Temple CL; Scilley CG; Engel CJ; Shum DT; Lohmann RC; Mattar AG; Zabel PL
Ann Plast Surg; 2000 Nov; 45(5):491-9. PubMed ID: 11092358
[TBL] [Abstract][Full Text] [Related]
36. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
Stoffels I; Dissemond J; Pöppel T; Schadendorf D; Klode J
JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057
[TBL] [Abstract][Full Text] [Related]
37. Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas.
Maccauro M; Villano C; Aliberti G; Ferrari L; Castellani MR; Patuzzo R; Tshering D; Santinami M; Bombardieri E
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):245-51. PubMed ID: 16172570
[TBL] [Abstract][Full Text] [Related]
38. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy.
O'Brien CJ; Uren RF; Thompson JF; Howman-Giles RB; Petersen-Schaefer K; Shaw HM; Quinn MJ; McCarthy WH
Am J Surg; 1995 Nov; 170(5):461-6. PubMed ID: 7485733
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
40. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
